Novo Nordisk expands into cardiovascular disease with $725 million deal

·

·

Novo Nordisk expands into cardiovascular disease with $725 million deal

COPENHAGEN (Reuters) – Novo Nordisk (NOVOb.CO) has agreed to buy AstraZeneca spin-off Corvidia Therapeutics for an initial $725 million as the world’s largest diabetes drugmaker seeks to expand into cardiovascular disease treatments. FILE PHOTO: …
See Original Article

Carbon accounting for beginners

Carbon accounting for beginners. A new report from Rocky Mountain Institute in the U.S. explores the need for companies to disclose information about
See Original Article

Move over Microsoft: Google Cloud ties into Spain's Telefónica for cloud and 5G edge use cases

Google Cloud and Telefónica say their new alliance will spur digital transformations and the development of 5G technologies in Spain. (Telefónica). Share Facebook Twitter LinkedIn Email Print. Move over Microsoft, Google Cloud is elbowing its way into …
See Original Article

Why Boeing Shares Are Down Today

Shares of Boeing (NYSE:BA) fell 7% on Thursday morning after a key supplier to the aerospace giant said it was pausing work on components for Boeing’s 737 Max, raising fresh questions about production plans for the plane.
See Original Article

Boeing Stock Falls to Support Amid Signs of a Slowdown

The Boeing Company (BA) shares fell nearly 10% during Thursday’s session amid ongoing concerns over the 737 MAX. While Boeing plans a recertification flight later this month, the company sent the opposite message to Spirit AeroSystems Holdings, Inc.
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.